Neuroleptic Malignant Syndrome (NMS) is a serious medical condition that, although rare, can be life-threatening and requires immediate intervention. It typically occurs following the use of antipsychotic (neuroleptic) medications and affects the central nervous system, the muscular system, and the autonomic nervous system.
Neuroleptic Malignant Syndrome is a condition of vital importance for both patients and their families, as it is associated with medications used in psychiatric treatments. It is considered a medical emergency because it can lead to fatal outcomes if not recognized early.
The clinical significance of Neuroleptic Malignant Syndrome stems not only from its rarity but also from its ability to progress rapidly and insidiously and to affect multiple organ systems simultaneously. During the course of the disease, the body’s temperature regulation mechanism is disrupted, leading to uncontrolled and high fever; the accompanying severe muscle rigidity can cause widespread damage to muscle tissue and rhabdomyolysis. This condition poses a serious threat to many organs, particularly the kidneys. Additionally, conditions directly affecting vital functions—such as cardiac arrhythmias, blood pressure fluctuations, and respiratory failure—may arise.
For this reason, Neuroleptic Malignant Syndrome should be considered not merely as a drug side effect but as a medical emergency during the course of psychiatric treatment. It is of great importance for both physicians and patients to have a high level of awareness regarding this syndrome to ensure that early symptoms are not overlooked. Seeking immediate medical evaluation upon the development of fever, muscle rigidity, altered consciousness, or autonomic symptoms is the most critical factor in determining the course of the disease. With timely diagnosis, rapid discontinuation of the causative medication, and initiation of appropriate supportive therapy, NMS can be controlled in most cases; thereby, the risk of permanent organ damage and mortality can be significantly reduced.
What Causes Neuroleptic Malignant Syndrome?
The causes of Neuroleptic Malignant Syndrome are largely related to medications that suppress the dopamine system. The sudden and severe blockade of dopamine receptors in the brain disrupts the body’s temperature regulation and muscle control mechanisms.
The most common causes:
- Use of antipsychotic medications at high doses
- Rapid increase in medication dosage
- Concurrent use of multiple antipsychotic medications
- Sudden discontinuation of dopamine agonists
- Dehydration
- Infection or severe physical stress
Neuroleptic Malignant Syndrome does not occur in every individual; however, the likelihood of its occurrence is significantly increased in those with risk factors.
Neuroleptic Malignant Syndrome does not occur in every individual; however, the likelihood of its occurrence is significantly increased in those with risk factors. For this reason, antipsychotic treatment should be initiated at a low dose, titrated slowly, and patients should be kept under close clinical monitoring, particularly in those at risk. Recognizing early symptoms and discontinuing the medication in a timely manner significantly improves the course of the disease and the prognosis.
What Are the Symptoms of Neuroleptic Malignant Syndrome?
Symptoms of Neuroleptic Malignant Syndrome (NMS) typically appear within the first 1–2 weeks after starting antipsychotic medication; however, in some cases, they may develop months later or following an increase in the dose of a medication that has been used for a long time. Symptoms often have an abrupt onset and can rapidly worsen over hours to days. Early symptoms are often nonspecific and may be mistaken for an infection or other systemic illness; this can lead to a delayed diagnosis.
As the syndrome progresses, involvement of the musculoskeletal system, central nervous system, and autonomic nervous system becomes more pronounced. Patients’ general condition deteriorates rapidly, changes in consciousness may develop, and life-threatening complications may arise. Therefore, early recognition of NMS symptoms is of critical importance for prompt intervention.
The most common symptoms:
High fever
- Above 38.5°C
- Resistant to antipyretics (fever reducers)
Muscle Stiffness (Rigidity)
- Widespread muscle stiffness resembling a “lead pipe”
- Limited mobility
Altered consciousness
- Confusion
- Agitation
- Impaired consciousness
- Coma
Autonomic Nervous System Findings
- Rapid heart rate (tachycardia)
- Irregular blood pressure
- Excessive sweating
- Increased respiratory rate
The presence of these symptoms together is considered a serious warning sign for Neuroleptic Malignant Syndrome.
Neuroleptic Malignant Syndrome Diagnostic Criteria
A diagnosis of Neuroleptic Malignant Syndrome cannot be made with a single test. Clinical findings and laboratory results are evaluated together. A diagnosis of Neuroleptic Malignant Syndrome (NMS) cannot be made with a single specific laboratory test or imaging method. The diagnostic process relies heavily on clinical suspicion and requires a comprehensive evaluation of the patient’s medication history, clinical symptoms, and laboratory findings. NMS must always be considered in patients with a history of antipsychotic use who develop high fever, muscle rigidity, and altered consciousness within a short period.
One of the most critical aspects of diagnosis is that the condition can be confused with other conditions such as infection, sepsis, serotonin syndrome, or malignant hyperthermia in the early stages. Therefore, obtaining a detailed medical history and inquiring about a recent history of starting medication, increasing the dose, or discontinuing dopaminergic medications is of great importance. Additionally, since the clinical presentation can deteriorate rapidly, the diagnostic process must not delay treatment; treatment may be initiated even before the diagnosis is confirmed if there is strong clinical suspicion.
Although laboratory tests are not diagnostic on their own, they support the clinical evaluation and are valuable for monitoring the severity of the disease, potential complications, and response to treatment. Therefore, the diagnosis of NMS is made through a comprehensive approach in which clinical findings take precedence and laboratory results support the diagnosis.
Key diagnostic criteria:
Major Criteria
- High fever
- Severe muscle rigidity
- History of antipsychotic medication use
Minor Criteria
- Altered consciousness
- Tachycardia
- Blood pressure irregularities
- Leukocytosis (increased white blood cell count)
- Elevated creatine kinase (CK)
When making a diagnosis, conditions such as infections, serotonin syndrome, and malignant hyperthermia must be ruled out.
How Is Neuroleptic Malignant Syndrome Treated?
Treatment for Neuroleptic Malignant Syndrome must be administered in a hospital setting, preferably in an intensive care unit.
The basic steps of treatment:
1. Immediate Discontinuation of the Causative Medication
2. Intensive Supportive Care
- Fluid therapy
- Fever control
- Electrolyte balance
3. Muscle Relaxants and Dopamine Agonists
- As determined by the physician based on the clinical condition
4. Prevention of Complications
- Renal failure
- Respiratory failure
- Cardiac arrhythmias